The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
CD44 is a cell surface HA-binding glycoprotein that is overexpressed to some extent by almost all tumors of epithelial origin and plays an important role in tumor initiation and metastasis. CD44 is a compelling marker for cancer stem cells of many solid malignancies. In addition, interaction of HA a...
Saved in:
Main Authors: | Ranjeeta Thapa, George D. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/2087204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
by: Appalaraju Jaggupilli, et al.
Published: (2012-01-01) -
The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells
by: Sabrina Bimonte, et al.
Published: (2016-01-01) -
AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer
by: Hong Wang, et al.
Published: (2025-01-01) -
Cardiovascular Effects Mediated by HMMR and CD44
by: Kinga Jaskuła, et al.
Published: (2021-01-01) -
Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
by: Jiangang Zhao, et al.
Published: (2017-01-01)